CVS Health Corp holds a focused book of 21 reported positions worth $225.2M as of Q2 2026 (disclosed Aug 6, 2026, a ~37-day 13F lag). This quarter they opened Ishr Ibx Usd Invgd CB ETF-Ui and trimmed Invesco S&P 500 Equal Weight. Their largest long position is Ishares 1-5Y Inv Grade Corp at 21% of the reported non-option book.
Top-heavy: focused book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
0% mapped to company sectors
+1 sector below the cut, under 0.5% together
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices (an exit at the prior quarter-end), no cost basis
Other tracked managers holding the same core names as CVS Health Corp
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| PartnerRe Asset Management CORP | 2 / 21 | $141.5M |
| Members Capital Advisors Inc | 4 / 21 | $101.0M |
| United Services Automobile Association | 3 / 21 | $1.0B |
| Japan Science & Technology Agency | 5 / 21 | $3.1B |
| Endurance Services Ltd | 3 / 21 | $331.1M |
| Crabel Capital Management, LLC | 10 / 21 | $63.5M |
| JBGlobal.com LLC | 3 / 21 | $48.9M |
| Invariant Investment Management | 6 / 21 | $66.9M |
Ranked by the share of each fund's own book sitting in the names it shares with CVS Health Corp: only funds sharing at least a tenth of the book qualify. Index giants, bank custody books and market makers are excluded. They hold everything, so their overlap says nothing.
Bars show each position's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Ishares TR ISHS 1-5YR INVS | $46.6M | 890.0K | 20.7% | ▲+202% Added · +596K sh | |
| 2 | Ishares TR ISHS 5-10YR INVT | $23.4M | 440.0K | 10.4% | ▲+374% Added · +347K sh | |
| 3 | Ishares TR 3 7 YR TREAS BD | $21.5M | 182.8K | 9.5% | —Held | |
| 4 | Ishares TR 1 3 YR TREAS BD | $21.2M | 258.1K | 9.4% | ▲+11% Added · +25K sh | |
| 5 | Ishares TR BROAD USD HIGH | $17.7M | 478.1K | 7.9% | ▲+37% Added · +130K sh | |
| 6 | Ishares TR JPMORGAN USD EMG | $17.4M | 180.0K | 7.7% | ▲+68% Added · +73K sh | |
| 7 | Ishares TR CORE US AGGBD ET | $14.8M | 149.7K | 6.6% | —Held | |
| 8 | Vanguard Scottsdale FDS SHRT TRM CORP BD | $9.5M | 120.0K | 4.2% | —Held | |
| 9 | Ishares TR 10+ YR INVST GRD | $8.8M | 175.0K | 3.9% | ▲+75% Added · +75K sh | |
| 10 | Ishares TR IBOXX INV CP ETF | $7.6M | 70.0K | 3.4% | ▲New New position | |
| 11 | Ishares TR IBOXX HI YD ETF | $7.2M | 90.0K | 3.2% | ▲New New position | |
| 12 | Vanguard Scottsdale FDS INTER TERM TREAS | $5.0M | 85.0K | 2.2% | —Held | |
| 13 | Janus Detroit STR TR HENDRSON AAA CL | $5.0M | 98.8K | 2.2% | —Held | |
| 14 | J P Morgan Exchange Traded F ULTRA SHRT ETF | $5.0M | 98.5K | 2.2% | —Held | |
| 15 | Vanguard Scottsdale FDS INT-TERM CORP | $5.0M | 60.0K | 2.2% | —Held | |
| 16 | Ishares TR 20 YR TR BD ETF | $4.3M | 50.0K | 1.9% | ▲+150% Added · +30K sh | |
| 17 | Ishares TR 7-10 YR TRSY BD | $3.3M | 35.0K | 1.5% | —Held | |
| 18 | Roundhill ETF Trust MEMORY ETF | $739K | 10.0K | 0.3% | ▲New New position | |
| 19 | Direxion Shares ETF Trust AUSPCE CMD STG | $489K | 15.0K | 0.2% | ▲New New position | |
| 20 | Invesco Exchange Traded FD T S&P500 EQL WGT | $426K | 2.0K | 0.2% | ▼−91% Reduced · −21K sh | |
| 21 | Prudential Finl Inc COM | $290K | 2.7K | 0.1% | —Held |
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/64803/holdings"
Use Arkolith to show CVS HEALTH Corp's latest holdings, largest changes, and filing provenance.
As-of date vs the date the SEC received each filing
Reported 13F total per quarter. Raw filing totals can include option notional.
| Quarter | As of | Filed | Lag | Positions | Value | Form |
|---|---|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | Aug 6, 2026 | 37d | 21 | $225.2M | 13F-HR |
| Q1 2026 | Mar 31, 2026 | May 7, 2026 | 37d | 33 | $212.3M | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 13, 2026 | 44d | 9 | $135.3M | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Oct 31, 2025 | 31d | 3 | $102.9M | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 1, 2025 | 32d | 3 | $190.6M | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 2, 2025 | 32d | 3 | $172.7M | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 13, 2025 | 44d | 3 | $233.7M | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 8, 2024 | 39d | 5 | $230.2M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. Book totals and portfolio weights cover reported non-option positions, which can include notes and warrants. Disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.